An Innovation-driven Biopharmaceutical Company

Mabwell (SSE: 688062) is an innovation-driven biopharmaceutical company with an entire industry chain of R&D, manufacturing, and commercialization. Consistent with our commitment to provide more effective and accessible therapies and innovative products, Mabwell has worked to fulfill global medical needs and bring life-changing solutions to patients.

01. World-leading Drug Discovery Platforms
02. Effective & Efficient Development Platforms
03. Robust Manufacturing Capabilities
04. Commercialization with Global Prospective